Next-generation molecular diagnostic tool for SARS-CoV-2 variant detection utilizing πCode technology. Addresses evolving viral variant challenges in infectious disease testing.
Manufactured by
Taipei City, Taiwan
About PlexBio PlexBio Co., Ltd., founded in 2010 and headquartered in Taiwan, is a leading developer and manufacturer of multiplex in vitro diagnostic (IVD) solutions tailored for precision medicine. At the core of PlexBio s innovation is the patented πCode® MicroDisc technology, enabling simultaneous detection of dozens to hundreds of genetic mutations or biomarkers in a single reaction. This forms the basis of the IntelliPlex® platform , supporting applications in oncology, infectious diseases, and immunoassays. To streamline laboratory workflows, PlexBio developed the IntelliPrep TRIO 240 —a fully automated sample preparation system that integrates nucleic acid extraction, quantification, normalization, and PCR assay setup. Supporting up to 24 samples per run, TRIO 240 reduces hands-on time and minimizes human error, while ensuring standardized sample prep for downstream applications such as qPCR, dPCR, NGS, or PlexBio's πCode-based detection. PlexBio is committed to improving diagnostic accuracy, reducing testing costs, and enhancing patient outcomes by delivering innovative, scalable, and cost-effective molecular testing solutions. With ISO 13485, GMP, CE-IVD, and FDA-listed products, PlexBio continues to expand globally through clinical collaborations, RUO/LDT applications, and distribution partnerships.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Applied Biocode, Inc.
United States · 3 relevant products
KogeneBiotech Co., Ltd.
South Korea · 3 relevant products
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 4 relevant products
Innobiochips SAS
France · 2 relevant products
Hicomp Microtech(Suzhou) Co., Ltd.
China · 1 relevant product
Bio-Techne Diagnostics
United States · 1 relevant product
DIA.PRO Diagnostic BioProbes Srl
Italy · 3 relevant products
SeeGene Middle East FZE
South Korea · 1 relevant product
Sentinel CH. SpA
Italy · 1 relevant product
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 80 closest product alternatives
Applied Biocode, Inc. · United States
Molecular diagnostic assay for detection of SARS-CoV-2. FDA-cleared in vitro diagnostic test providing reliable identification of COVID-19 infection.
KogeneBiotech Co., Ltd. · South Korea
Specialized real-time PCR diagnostic test for detection and identification of SARS-CoV-2 Omicron variant. This molecular assay enables variant-specific diagnostics for epidemiological monitoring and clinical management.
Applied Biocode, Inc. · United States
Multiplex molecular diagnostic assay for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B. Enables comprehensive respiratory pathogen screening in single test format.
Applied Biocode, Inc. · United States
A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid diagnostic test for detecting SARS-CoV-2 and future variants at the point of care. Plays a crucial role in infection control and prevention of viral spread.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid and accurate diagnostic test for simultaneous detection of influenza and COVID-19 at the point of care. Enables differentiation between respiratory pathogens in 20 minutes.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
Rapid molecular diagnostic assay for simultaneous detection of SARS-CoV-2, influenza, and RSV. Delivers real-time PCR results in 20 minutes from sample collection, enabling point-of-care testing and immediate clinical decision-making. Designed for deployment in clinical settings to reduce turnaround time and diagnostic costs.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A multiplex real-time PCR assay for the VitaPCR™ platform that simultaneously detects Influenza and SARS-CoV-2 from patient samples.
KogeneBiotech Co., Ltd. · South Korea
Real-time PCR molecular diagnostic test for detection of SARS-CoV-2 virus. This assay enables rapid identification of COVID-19 infection through quantitative PCR methodology. The test was among the first developed and supplied in Korea.
Innobiochips SAS · France
An advanced COVID-19 diagnostic tool based on Innobiochips' proprietary high-resolution multiplex assay technology. CoViDiag represents the most advanced diagnostic solution for COVID-19 detection and is used for infectious disease diagnostics.
Innobiochips SAS · France
High-resolution multiplex COVID-19 diagnostic assay based on proprietary Siryus technology. Provides advanced detection capabilities for infectious disease diagnostics.
68 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products